Laurent Tillement Selected Research

25R)-20alpha-spirost-5-en-3beta-yl hexanoate (22R

3/2009	Caprospinol: moving from a neuroactive steroid to a neurotropic drug.
8/2006	The spirostenol (22R, 25R)-20alpha-spirost-5-en-3beta-yl hexanoate blocks mitochondrial uptake of Abeta in neuronal cells and prevents Abeta-induced impairment of mitochondrial function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurent Tillement Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 01/2011 - 03/2009
2	Neuroblastoma 01/2011 - 08/2006

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 05/2010 - 03/2009
2	25R)-20alpha-spirost-5-en-3beta-yl hexanoate (22RIBA 03/2009 - 08/2006
1	Adenylate KinaseIBA 01/2011
1	EnzymesIBA 01/2011
1	Amyloid (Amyloid Fibrils)IBA 01/2011
1	carbamic acid (ammonium carbamate)IBA 05/2010
1	Biological ProductsIBA 05/2010
1	EstersIBA 05/2010
1	22-hydroxycholesterolIBA 03/2009
1	NeurosteroidsIBA 03/2009
1	CholesterolIBA 03/2009
1	SteroidsIBA 03/2009
1	Neuroprotective AgentsIBA 08/2006
1	oxophenylarsine (phenylarsine oxide)IBA 08/2006